Less commonly, GLP-1 medications carry warnings for more serious risks, including pancreatitis, gallbladder problems, and possible thyroid tumors
A systematic review found that hair loss associated with GLP-1 receptor agonist use is a documented phenomenon, primarily related to the telogen effluvium triggered by rapid weight loss and nutritional deficiency rather than a direct drug effect
Retatrutide achieved up to 24.2% body weight reduction over 48 weeks in the Phase 2 trial published in the New England Journal of Medicine , which involved adults with obesity but without diabetes
Start Your Semaglutide Journey with Klinic Klinic pioneers a simple, efficient way to embark on semaglutide treatment in California
Understanding the potential side effects of any medication, including semaglutide, is crucial for managing your health effectively
Since the start of 2025, OZEM is up 28.62%, sharply outpacing the S&P 500 Health Care Sector (8.55%) and the broader S&P 500 Index (12.76%)